A diagnostic test series utilizing immunofluorescence quantitative methodology for clinical immune diagnosis and measurement of various biomarkers.
Manufactured by
China
Shenzhen Anqun Biotech Co., Ltd., established in 1994, is a national high-tech enterprise specializing in R&D and manufacturing of in-vitro diagnostic reagents. The company holds 53 product registration certificates covering ELISA reagents in 9 series including infertility, respiratory diseases, and early Alzheimer's screening. Anqun maintains 16 granted invention patents and collaborates with leading universities including Sun Yat-sen University and Capital Medical University.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
AssureTech.(Hangzhou) Co.,Ltd.
China · 2 relevant products
B&C Biological
China · 1 relevant product
Zhuhai Encode Medical Engineering Co Ltd
China · 2 relevant products
45 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 69 closest product alternatives
AssureTech.(Hangzhou) Co.,Ltd. · China
A comprehensive series of diagnostic tests for the detection of various infectious diseases. These products enable rapid identification of pathogenic infections.
AssureTech.(Hangzhou) Co.,Ltd. · China
A series of diagnostic tests for the detection of inflammatory markers and biomarkers. These products enable rapid identification of inflammatory conditions.
B&C Biological · China
A POCT-series rapid quantitative immunodetection system designed for point-of-care testing applications. The system uses immunofluorescence lateral flow detection methodology and can process whole blood, serum, or plasma samples. It offers a detection throughput of 80 tests per hour with precision (CV) less than 3%, and is capable of detecting multiple analytes including C-reactive protein, procalcitonin, cardiac troponin I, CK-MB, myoglobin, D-dimer, NT-proBNP, serum amyloid A, and influenza A and B.
66 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products